CMS updated its novel coronavirus (COVID-19) billing and coding FAQs on April 9 to address new information on payment for specimen collection, diagnostic laboratory services, and hospital services including temporary expansion sites.
While the healthcare industry rightfully remains focused on handling the COVID-19 pandemic, compliance officers should also be aware of two rules that dropped in early March.
This week's note from the instructor walks through the various provisions of CMS' interim final rule on policy and regulatory changes during the COVID-19 pandemic.
The U.S. Department of Health and Human Services (HHS) will reimburse hospitals at Medicare rates for treating uninsured novel coronavirus (COVID-19) patients.
